Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

4.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

996
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
996
Clinical Trials01:16

Clinical Trials

8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Drug Regulation01:25

Drug Regulation

3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psoriatic arthritis and obesity: a review of clinical burden and considerations for comprehensive care.

RMD open·2026
Same author

Health Data Quality Skill Gaps and Training Needs Among European Health Data Stakeholders: Cross-Sectional Survey.

Journal of medical Internet research·2026
Same author

Predictive models for graft rejection and infections in renal transplant patients based on TTV viral load.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2026
Same author

Transitional initiatives for advancing the phasing out of the use of animals for drug and chemical safety testing: The IHI VICT3R project for reducing the use of animals by implementing virtual control groups.

NAM journal·2026
Same author

Storage Stability of a Multifunctional Fermented Blend Based on Sacha Inchi (<i>Plukenetia volubilis</i>) Oil Press Cake and Yacon (<i>Smallanthus sonchifolius</i>) Flour: Physicochemical Properties, Bioactivity, and Prebiotic-Probiotic Potential.

Foods (Basel, Switzerland)·2026
Same author

Knowledge, attitude, and practice survey for patient blood management in India: An initiative by the special interest group of the Indian Society of Transfusion Medicine.

Asian journal of transfusion science·2026

Related Experiment Video

Updated: May 4, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.8K

Gathering and exploring scientific knowledge in pharmacovigilance.

Pedro Lopes1, Tiago Nunes1, David Campos1

  • 1DETI/IEETA, University of Aveiro, Aveiro, Portugal.

Plos One
|December 19, 2013
PubMed
Summary

A new platform enhances pharmacovigilance by integrating researchers, data, and algorithms. This facilitates faster identification of drug-adverse event interactions and their underlying evidence.

More Related Videos

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
09:18

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Published on: March 31, 2022

2.2K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

11.3K

Related Experiment Videos

Last Updated: May 4, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.8K
Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
09:18

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Published on: March 31, 2022

2.2K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

11.3K

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Bioinformatics and Computational Biology
  • Health Informatics

Background:

  • Pharmacovigilance is crucial for monitoring drug effects but faces technological stagnation due to various constraints.
  • Collaborative and integrative approaches are increasingly recognized as vital for advancing drug research and development.
  • Existing pharmacovigilance efforts are hindered by fragmented data, knowledge, and analysis tools.

Purpose of the Study:

  • To introduce a novel platform designed for pharmacovigilance knowledge providers.
  • To address fundamental challenges in pharmacovigilance software through an innovative architectural approach.
  • To enable better utilization of clinical and pharmaceutical data for drug safety assessments.

Main Methods:

  • Development of a service-oriented architecture (SOA) for the pharmacovigilance platform.
  • Implementation of a plugin-based system to enhance software flexibility and address challenges.
  • Integration of researchers, datasets, biomedical knowledge, and analysis algorithms within a unified ecosystem.

Main Results:

  • The platform enables the connection of knowledge providers' algorithms with real-world clinical and pharmaceutical data.
  • Facilitates faster identification of high-risk interactions between marketed drugs and adverse events.
  • Supports the automated uncovering of scientific evidence substantiating identified drug-adverse event relationships.

Conclusions:

  • The proposed platform offers a new ecosystem for coordinating large-scale drug evaluation efforts in pharmacovigilance.
  • This integrated approach promises to accelerate the discovery and validation of drug safety signals.
  • The system provides a publicly accessible resource to advance the field of pharmacovigilance.